Skip to main content
Erschienen in: Critical Care 1/2021

Open Access 01.12.2021 | Research

Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry

verfasst von: Ryuta Nakae, Tetsuro Sekine, Takashi Tagami, Yasuo Murai, Eigo Kodani, Geoffrey Warnock, Hidetaka Sato, Akio Morita, Hiroyuki Yokota, Shoji Yokobori

Erschienen in: Critical Care | Ausgabe 1/2021

Abstract

Background

Sepsis is often associated with multiple organ failure; however, changes in brain volume with sepsis are not well understood. We assessed brain atrophy in the acute phase of sepsis using brain computed tomography (CT) scans, and their findings’ relationship to risk factors and outcomes.

Methods

Patients with sepsis admitted to an intensive care unit (ICU) and who underwent at least two head CT scans during hospitalization were included (n = 48). The first brain CT scan was routinely performed on admission, and the second and further brain CT scans were obtained whenever prolonged disturbance of consciousness or abnormal neurological findings were observed. Brain volume was estimated using an automatic segmentation method and any changes in brain volume between the two scans were recorded. Patients with a brain volume change < 0% from the first CT scan to the second CT scan were defined as the “brain atrophy group (n = 42)”, and those with ≥ 0% were defined as the “no brain atrophy group (n = 6).” Use and duration of mechanical ventilation, length of ICU stay, length of hospital stay, and mortality were compared between the groups.

Results

Analysis of all 42 cases in the brain atrophy group showed a significant decrease in brain volume (first CT scan: 1.041 ± 0.123 L vs. second CT scan: 1.002 ± 0.121 L, t (41) = 9.436, p < 0.001). The mean percentage change in brain volume between CT scans in the brain atrophy group was –3.7% over a median of 31 days, which is equivalent to a brain volume of 38.5 cm3. The proportion of cases on mechanical ventilation (95.2% vs. 66.7%; p = 0.02) and median time on mechanical ventilation (28 [IQR 15–57] days vs. 15 [IQR 0–25] days, p = 0.04) were significantly higher in the brain atrophy group than in the no brain atrophy group.

Conclusions

Many ICU patients with severe sepsis who developed prolonged mental status changes and neurological sequelae showed signs of brain atrophy. Patients with rapidly progressive brain atrophy were more likely to have required mechanical ventilation.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s13054-021-03828-7.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
APACHE
Acute physiology and chronic health evaluation
CAM-ICU
Confusion assessment method for the intensive care unit
CBF
Cerebral blood flow
CBV
Cerebral blood volume
CPP
Cerebral perfusion pressure
CRRT
Continuous renal replacement therapy
CSF
Cerebrospinal fluid
CT
Computed tomography
DIC
Disseminated intravascular coagulation
GCS
Glasgow Coma Scale
GM
Gray matter
ICP
Intracranial pressure
ICU-AW
Intensive care unit-acquired weakness
ICU
Intensive care unit
IQR
Interquartile range
J-SSCG
Japanese clinical practice guidelines for management of sepsis and septic shock
JAAM
Japanese association for acute medicine
MNI
Montreal Neurological Institute
MODS
Multiorgan dysfunction syndrome
MRC
Medical Research Council
MRI
Magnetic resonance imaging
PEEP
Positive end-expiratory pressure
rhTM
Recombinant human soluble thrombomodulin
SD
Standard deviation
SOFA
Sequential organ failure assessment
SPM
Statistical parametric mapping
WM
White matter

Background

Advances in the treatment of sepsis have improved short-term outcomes and increased the survival rate [1, 2]. However, it has been reported that long-term outcomes have not improved [36]. A secondary analysis of the “A Controlled Comparison of Eritoran and placebo in patients with Severe Sepsis” (ACCESS) trial and the “Prospective Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis” (PROWESS)-SHOCK trial found that of those surviving after treatment for severe sepsis, 33.1% and 34.3% had not returned to independent living by 6 months, respectively [46]. Brinkman et al. [3] reported that most intensive care unit (ICU) patients were still at higher risk of death than the general population in the years after discharge, and that those patients admitted for acute renal failure or pneumonia had a mortality rate of > 40% in the 3 years after discharge. Recently, there have been several reports using magnetic resonance imaging (MRI) on the relationship between brain volume reduction and prognosis in patients receiving treatment in the ICU [7, 8]. Gunther et al. [7] found that in survivors treated in the ICU, the longer the duration of delirium, the smaller the brain volume up to 3 months after discharge, and smaller brain volume was associated with long-term cognitive impairment up to 12 months. Orhun et al. [8] reported that 16.1% of patients with sepsis-induced brain dysfunction had brain atrophy. Thus, it is important to evaluate changes in brain volume in the acute phase in critically ill patients; however, in clinical practice, MRI is difficult to obtain if the patient is on vasopressors or has unstable vital signs. In such a situation, images for neurological evaluation can only be obtained with head computed tomography (CT).
In this study, we examined the brain atrophy rate in the acute phase of sepsis using head CT scans, and its relationship to risk factors and outcomes.

Methods

We retrospectively analyzed demographic, clinical, and radiologic data of 555 consecutive sepsis cases treated at the Department of Emergency and Critical Care Medicine, Nippon Medical School Hospital, from January 2015 to December 2020. Diagnosis of sepsis was based on the Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016) [9]. The J-SSCG2016 covers a total of 19 clinical areas and includes 89 clinical questions, and was developed to meet the needs of clinicians managing conditions including sepsis and disseminated intravascular coagulation (DIC). It was developed by 19 committee members and 52 working group members selected from the Japanese Society of Intensive Care Medicine and the Japanese Association for Acute Medicine (JAAM), in accordance with the procedures of the Medical Information Network Distribution Service (Minds). Exclusion criteria included age < 16 y; hospital length of stay < 15 d; comorbidities that may affect brain atrophy such as hypoxemia (PaO2 < 60 mmHg) at admission, aneurysmal subarachnoid hemorrhage, intracerebral hemorrhage, cerebral infarction, traumatic brain injury, meningitis, carbon monoxide poisoning, drug toxicity, status epilepticus, hypoxic encephalopathy, brain death, hematological disease, and malignant disease; only a single CT scan during hospitalization; and the longest CT scan interval during hospitalization < 15 d. This resulted in a total of 48 cases (Fig. 1).
We collected data on patient age; sex; past history of hypertension, diabetes mellitus, and atrial fibrillation; Glasgow Coma Scale (GCS) score, sequential organ failure assessment (SOFA) score [10], acute physiology and chronic health evaluation (APACHE) II score [11], and JAAM DIC score [12] at the time the diagnosis of sepsis was made; use of mechanical ventilation, vasopressor, heparin, antithrombin, and recombinant human soluble thrombomodulin (rhTM); and implementation of continuous renal replacement therapy (CRRT) and surgery.

Management of sepsis

Treatment was administered immediately at the time of diagnosis based on J-SSCG 2016 [9]. In our institution, brain CT scans are routinely performed on septic patients at the time of admission (first CT scan). A second or further brain CT scans are obtained whenever prolonged disturbance of consciousness or abnormal neurological findings are observed. Here, when CT scans were acquired ≥ 3 times, the last CT scan acquired during hospitalization was adopted as the second CT scan. Treatment options such as heparin, antithrombin, rhTM, CRRT, and surgery were at the discretion of the treating physician.

Evaluation of brain volume

Brain volume was automatically calculated from clinical routine CT images with 5 mm thick sections using commercial software (PMOD Version 4.002, PMOD Technologies Ltd., Zurich, Switzerland). We applied the methodology described by Adduru et al. [13, 14]. Briefly, intensity transformation was applied to original brain CT image data to enhance the tissue contrast between gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF). Then, the scaled data were nonrigidly transformed to predefined template CT images as proposed by Rorden et al. [15]. As a result, the transformed images were registered to Montreal Neurological Institute (MNI) space. Six-compartment tissue segmentation using standard statistical parametric mapping (SPM) software Version 12 was adopted to separate GM, WM, CSF, bone, air, and other components according to the method of Ashburner and Friston [16]. The segmented images were then inversely transformed from MNI space to the original patients’ specific CT space. A volume of interest was drawn to include GM and WM to calculate the brain volume (Fig. 2). All steps were automatically performed without any user interaction.
After the calculation, one neuroradiologist (T.S.) validated the results of segmentation without any clinical information such as patient background or scan order (i.e. first or second). Seven datasets with segmentation error were excluded. Four had severe motion artifact either in the first or second CT scan and three had misclassification of CSF due to abnormal brain morphology.

Group classification

After assessing for change in brain volume between the first and second CT scans, we assigned patients with brain volume change < 0% from the first CT scan to the second CT scan to the “brain atrophy group (n = 42)” and those with ≥ 0% to the “no brain atrophy group (n = 6).” The demographic characteristics of each group were compared, including the need for and length of time on mechanical ventilation, length of ICU stay, length of hospital stay, mortality, prevalence of delirium as assessed using the confusion assessment method for the intensive care unit (CAM-ICU) [17] until second CT scan, and Medical Research Council (MRC) score. The MRC score, ranging from 0 to 60, was assessed during early awakening in surviving patients as an indicator of ICU-acquired weakness (ICU-AW) using six prespecified muscle groups [18]. CAM-ICU assessments were performed every 12 h by nurses, and MRC scores were assessed by physical therapists for muscle strength and scored by physicians.

Statistical analysis

Data are expressed as number (%), mean (standard deviation: SD), or median (interquartile range: IQR). Continuous variables were compared between groups using Student’s t-test or the Mann–Whitney U-test, and categorical variables using the χ2 test. A value of p < 0.05 was considered statistically significant. All statistical analyses were performed using commercial software (SPSS Version 25.0®; IBM Corp., Armonk NY, USA).

Results

Analysis of all 42 cases in the brain atrophy group showed a significant decrease in brain volume (first CT scan: 1.041 ± 0.123 L vs. second CT scan: 1.002 ± 0.121 L, t (41) = 9.436, p < 0.001) (Fig. 3). Brain atrophy was diffuse, and not focal, in all cases.
Demographic and clinical characteristics of patients are summarized in Table 1. Median (IQR) of SOFA score and APACHE II score of the eligible cases were as high as 13 (11–15) and 27 (21–31), respectively, indicating that many cases with severe sepsis were included in the study. In addition, 39 (81.3%) cases met the DIC diagnostic criteria of JAAM DIC score ≥ 4. The groups were comparable with regard to age; sex; presence of medical histories such as hypertension, diabetes mellitus, and atrial fibrillation; and clinical scores such as GCS score, SOFA score, APACHE II score, and JAAM DIC score. The incidence of mechanical ventilation use was significantly higher in the brain atrophy group than in the no brain atrophy group (95.2% vs. 66.7%, p = 0.02) (Table 1).
Table 1
Characteristics of the study population
Characteristic
Total (n = 48)
Brain atrophy group (n = 42)
No brain atrophy group (n = 6)
p
Demographics
    
Age, median (IQR), years
73 (63–80)
73 (63–79)
79 (68–84)
0.26
Male, n (%)
31 (64.6)
28 (66.7)
3 (50.0)
0.43
Medical history
    
Hypertension, n (%)
16 (33.3)
13 (31.0)
3 (50.0)
0.36
Diabetes mellitus, n (%)
14 (29.2)
13 (31.0)
1 (16.7)
0.48
Atrial fibrillation, n (%)
10 (20.8)
9 (21.4)
1 (16.7)
0.79
Clinical score
    
GCS score, median (IQR)
12 (8–14)
13 (9–14)
10 (3–13)
0.18
SOFA score, median (IQR)
13 (11–15)
14 (11–15)
11 (9–15)
0.29
APACHE II score, median (IQR)
27 (21–31)
27 (24–31)
28 (16–31)
0.63
JAAM DIC score, median (IQR)
6 (4–7)
6 (4–7)
5 (3–6)
0.26
Treatment
    
Mechanical ventilation, n (%)
44 (91.7)
40 (95.2)
4 (66.7)
0.02
Vasopressors, n (%)
38 (79.2)
35 (83.3)
3 (50.0)
0.06
Heparin, n (%)
5 (10.4)
5 (11.9)
0 (0.0)
0.38
Antithrombin, n (%)
15 (31.3)
13 (31.0)
2 (33.3)
0.91
rhTM, n (%)
13 (27.1)
12 (28.6)
1 (16.7)
0.54
CRRT, n (%)
37 (77.1)
34 (81.0)
3 (50.0)
0.10
Surgery, n (%)
12 (25.0)
12 (28.6)
0 (0.0)
0.14
Significant value is given in bold
Table 2 shows the brain volumes and other outcomes. The mean percentage change of brain volume between CT scans in the brain atrophy group was –3.7% (equivalent to a brain volume of 38.5 cm3) over a median of 31 days. The mortality rate did not significantly differ between the two groups. In patients on mechanical ventilation, the median length of mechanical ventilation was significantly higher in the brain atrophy group than in the no brain atrophy group (28 [IQR: 15–57] days vs. 15 [IQR: 0–25] days, p = 0.04) (Table 3). Excluding the 12 patients who remained comatose until the second CT scan or with a history of severe dementia, the incidence of delirium in both groups reached 66.7% (Table 4). Among patients without limb paralysis, the median MRC scores decreased substantially from the full score of 60 in both groups, suggesting muscle weakness, but with no significant difference between the two groups (Table 5).
Table 2
Clinical results
 
Total (n = 48)
Brain atrophy group (n = 42)
No brain atrophy group (n = 6)
p
Radiological findings
    
Brain volume at 1st CT scan, mean ± SD, L
1.033 ± 0.120
1.041 ± 0.123
0.975 ± 0.072
0.16
Brain volume at 2nd CT scan, mean ± SD, L
1.000 ± 0.114
1.002 ± 0.121
0.986 ± 0.064
0.80
Percent change of brain volume, mean ± SD, %
–3.1 ± 2.9
–3.7 ± 2.6
1.2 ± 1.4
 < 0.001
Number of days between CT scans, median (IQR), days
29 (18–46)
31 (19–49)
20 (17–23)
0.07
Length of stay/mortality
    
Length of ICU stay, median (IQR), days
28 (15–45)
28 (15–48)
17 (3–31)
0.15
Length of hospital stay, median (IQR), days
41 (28–70)
45 (28–72)
30 (25–54)
0.29
Mortality, n (%)
14 (29.2)
11 (26.2)
3 (50.0)
0.24
Significant value is given in bold
Table 3
Time on mechanical ventilation and brain atrophy rate
 
Total (n = 44)
Ventilated brain atrophy group (n = 40)
Ventilated no brain atrophy group (n = 4)
p
Length of time on mechanical ventilation, median (IQR), days
27 (14–52)
28 (15–57)
15 (0–25)
0.04
Significant value is given in bold
Table 4
Prevalence of delirium until second CT scan
 
Total (n = 36)
Brain atrophy group (n = 33)
No brain atrophy group (n = 3)
p
Delirium, n (%)
24 (66.7)
22 (66.7)
2 (66.7)
1.00
Table 5
Medical Research Council score in surviving patients
 
Total (n = 31)
Brain atrophy group survivors (n = 28)
No brain atrophy group survivors (n = 3)
p
MRC score, median (IQR)
36 (24–48)
33 (24–48)
48 (36–60)
0.09

Discussion

We found significant brain atrophy in patients with severe sepsis with a mean decrease in brain volume of − 3.7% (38.5 cm3) over a median of 31 days. Further brain atrophy was associated with the use and length of time on mechanical ventilation.
We have often observed the occurrence of brain atrophy in septic patients during a relatively short period of hospitalization (Additional file 1, 2: Figs. S1 and S2). Cerebral infarction due to hypoperfusion or DIC in septic patients has been reported [19, 20]. Although impaired cerebral blood flow (CBF) may be responsible for the atrophy observed in the present study, the mechanism is considered to differ from that with common cerebral infarction because there were no cases with new low-density areas on CT scans, and the atrophy was observed diffusely rather than focally. Considering that 35 (83.3%) of the 42 patients in the brain atrophy group were diagnosed with DIC with a JAAM DIC score ≥ 4 and that these patients were in a hypercoagulable state [21], diffuse atrophic change may have progressed due to diffuse infarction caused by microthrombi that were not reflected on CT scan. Chang [22] stated that in patients with sepsis, endotheliopathy is caused by the membrane-attack complex generated by complement activation, resulting in microthrombus formation and multiorgan dysfunction syndrome (MODS) caused by disseminated intravascular microthrombosis. We speculate that the same mechanism may be responsible for the occurrence of diffuse cerebral atrophy observed in this study as one of the MODS.
Our findings also suggest that rapidly progressive cerebral atrophy in septic patients was associated with mechanical ventilation. Although mechanical ventilation has the effect of improving oxygenation and alveolar recruitment, the increase in intrathoracic pressure caused by positive end-expiratory pressure (PEEP) can increase jugular venous pressure and inhibit cerebral venous outflow [23]. Impaired venous outflow leads to increased cerebral blood volume (CBV), resulting in increased intracranial pressure (ICP), potentially decreasing CBF [24, 25]. In addition, in patients with hemodynamic instability, PEEP up to 20 cm H2O has been shown to significantly decrease systemic venous return, leading to decreased cardiac output, which in turn decreases systemic blood pressure and cerebral perfusion pressure (CPP), decreasing CBF [26]. This mechanism is known as the Starling resistance model and represents the role of damaged venous outflow in the ICP response to PEEP [27]. This may act in concert with the cerebral hypoperfusion caused by sepsis. Recent animal studies have also suggested that brain atrophy associated with short-term mechanical ventilation may be caused by reduced amyloid-β clearance associated with brain outflow impairment [28].
Previous reports have shown that decreased brain volume is causally related to decreased motor and cognitive functions [2932]. Kido et al. [30] reported that atrophy in the left cerebellum and left prefrontal cortex was associated with reduced walking speed, while atrophy in the right putamen, right posterior superior parietal cortex, and cerebellum were associated with balance difficulties. Gado et al. [29] reported that volume expansion of the CSF space on CT was a highly sensitive indicator for detecting cognitive ability. Therefore, it is possible that brain atrophy is a factor in the development of cognitive and physical impairment. Adduru et al. [13] reported that the Alzheimer’s disease group had 1.7% lower brain volume than the control group using an automatic segmentation method with CT scans. An MRI study by Tabatabaei-Jafari et al. [33] showed that the rate of overall brain atrophy in patients with newly diagnosed Alzheimer’s disease ranged from 1.83 to 2.71% per year. These results suggest that the 3.7% reduction in brain volume in this study is not negligible. Inflammation, oxidative damage, and neuronal apoptosis associated with sepsis have also been reported to cause neuronal damage and brain dysfunction [34, 35] and these changes have been observed in patients with long-term cognitive impairment [36].
Gunther et al. [7] found that in ICU-treated survivors, longer duration of delirium was associated with smaller brain volume up to 3 months post-discharge. As a mechanism, some studies have reported that regional cerebral blood flow in the frontal, temporal, and occipital cortices, and in the thalamus, basal ganglia, and pons is greatly reduced during acute delirium [37, 38]. In our study, the number of patients with delirium was also high, at 66.7% of all patients, but there was no significant difference between the brain atrophy and the no brain atrophy groups. In addition, Harvey et al. [39] showed that ICU-AW developed in 25%–80% of people who are ventilated for > 4 d and in 50–75% of people with sepsis. Similar to their study, the MRC score as an assessment of motor function was substantially decreased in the target patients in this study, but there was no significant difference between the brain atrophy group and the no brain atrophy group. One reason that these investigations did not show differences may be that the size of the no brain atrophy group was so small.
Although several studies have evaluated brain volume changes in septic patients using MRI [7, 8], no study has evaluated brain volume changes using CT scans. We performed automatic brain segmentation to calculate brain volume from clinical routine CT images with 5 mm thick sections. The standard method of brain volumetry uses high-resolution MRI as input [40]. However, in the clinical setting, MRI is difficult to acquire when patients are on vasopressors and have unstable vital signs. In that situation, we can obtain only brain CT images for neurological assessment. In segmentation of the brain, the low tissue contrast in CT hampers the objective evaluation of brain volume. To overcome this drawback, CT-based brain-volume calculation utilizing pre-defined CT-template images has been developed [15]. Compared to the gold-standard MRI-based volume estimates, this approach is sensitive enough to yield brain volume estimates within 3–5% [14]. The clinical utility of CT brain volumetry has already been validated in the discrimination of Alzheimer’s disease from controls [13]. We excluded three patients due to errors in automatic tissue classification. This rate (5.8%, 3/51) is not inferior to the previous reports (11.2%, 17/152) [13].
The strength of this study is that we used automatic CT brain volumetry to quantitatively assess brain volume. This technique requires only a computational cost of about 15 min per patient dataset and does not require an experienced operator. As CT data are expressed in the same standardized values (Hounsfield units) among different scanners, this method can be accurately applied to any CT scanner in multiple institutions. This automatic approach would likely be highly useful in the conduct of a much larger/multi-center cohort.
There are several limitations to our study. First, it was conducted as a retrospective study and selection bias was inevitable. Of the 555 patients with sepsis, only 48 cases met the inclusion criteria. The prolonged disturbance of consciousness and abnormal neurological findings that triggered the CT scan may be related to brain atrophy, and may have overdetected patients who presented with brain atrophy. However, the short time between scans would eliminate any contribution of age-related atrophy. Further large prospective studies are needed to validate our results. Second, since this study included patients who had had multiple head CT scans, most of the patients presented with severe sepsis or DIC complications. We found that patients with severe sepsis had a higher incidence of brain atrophy, but this is not considered to be generalizable to sepsis. Third, since this study was conducted on septic patients, we could not compare brain volumes with those of non-septic patients. Therefore, the results of this study may not indicate that rapidly progressive brain atrophy is a change specific to sepsis. Fourth, we did not investigate cognitive decline associated with brain atrophy. Finally, multivariate analysis was not performed because it could be assumed that the statistical model would be unstable.

Conclusions

Many ICU patients with severe sepsis who developed prolonged mental status changes and neurological sequelae showed signs of brain atrophy. Patients with rapidly progressive brain atrophy were more likely to have required mechanical ventilation.

Acknowledgements

We thank Libby Cone, MD, MA, from DMC Corp. (www.​dmed.​co.​jp) for editing drafts of this manuscript.

Declarations

The Institutional Review Board of Nippon Medical School Hospital approved this study (B-2020-293) and waived the need for informed consent due to the observational nature of the study.
Not applicable.

Competing interests

One author (Geoffrey Warnock) is an employee of PMOD Technologies Ltd. Only non-PMOD employees had control of inclusion of data and information.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311:1308–16.CrossRef Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R. Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA. 2014;311:1308–16.CrossRef
2.
Zurück zum Zitat Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRef Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546–54.CrossRef
3.
Zurück zum Zitat Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Mortality after hospital discharge in ICU patients. Crit Care Med. 2013;41:1229–36.CrossRef Brinkman S, de Jonge E, Abu-Hanna A, Arbous MS, de Lange DW, de Keizer NF. Mortality after hospital discharge in ICU patients. Crit Care Med. 2013;41:1229–36.CrossRef
4.
Zurück zum Zitat Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309:1154–62.CrossRef Opal SM, Laterre PF, Francois B, LaRosa SP, Angus DC, Mira JP, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA. 2013;309:1154–62.CrossRef
5.
Zurück zum Zitat Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055–64.CrossRef Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med. 2012;366:2055–64.CrossRef
6.
Zurück zum Zitat Yende S, Austin S, Rhodes A, Finfer S, Opal S, Thompson T, et al. Long-term quality of life among survivors of severe sepsis: analyses of two international trials. Crit Care Med. 2016;44:1461–7.CrossRef Yende S, Austin S, Rhodes A, Finfer S, Opal S, Thompson T, et al. Long-term quality of life among survivors of severe sepsis: analyses of two international trials. Crit Care Med. 2016;44:1461–7.CrossRef
7.
Zurück zum Zitat Gunther ML, Morandi A, Krauskopf E, Pandharipande P, Girard TD, Jackson JC, et al. The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study*. Crit Care Med. 2012;40:2022–32.CrossRef Gunther ML, Morandi A, Krauskopf E, Pandharipande P, Girard TD, Jackson JC, et al. The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study*. Crit Care Med. 2012;40:2022–32.CrossRef
8.
Zurück zum Zitat Orhun G, Tuzun E, Bilgic B, Ergin Ozcan P, Sencer S, Barburoglu M, et al. Brain volume changes in patients with acute brain dysfunction due to sepsis. Neurocrit Care. 2020;32:459–68.CrossRef Orhun G, Tuzun E, Bilgic B, Ergin Ozcan P, Sencer S, Barburoglu M, et al. Brain volume changes in patients with acute brain dysfunction due to sepsis. Neurocrit Care. 2020;32:459–68.CrossRef
9.
Zurück zum Zitat Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016). J Intensive Care. 2018;6:7.CrossRef Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2016 (J-SSCG 2016). J Intensive Care. 2018;6:7.CrossRef
10.
Zurück zum Zitat Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.CrossRef Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707–10.CrossRef
11.
Zurück zum Zitat Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRef Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818–29.CrossRef
12.
Zurück zum Zitat Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625–31.CrossRef Gando S, Iba T, Eguchi Y, Ohtomo Y, Okamoto K, Koseki K, et al. A multicenter, prospective validation of disseminated intravascular coagulation diagnostic criteria for critically ill patients: comparing current criteria. Crit Care Med. 2006;34:625–31.CrossRef
13.
Zurück zum Zitat Adduru V, Baum SA, Zhang C, Helguera M, Zand R, Lichtenstein M, et al. A method to estimate brain volume from head CT images and application to detect brain atrophy in Alzheimer disease. AJNR Am J Neuroradiol. 2020;41:224–30.CrossRef Adduru V, Baum SA, Zhang C, Helguera M, Zand R, Lichtenstein M, et al. A method to estimate brain volume from head CT images and application to detect brain atrophy in Alzheimer disease. AJNR Am J Neuroradiol. 2020;41:224–30.CrossRef
14.
Zurück zum Zitat Irimia A, Maher AS, Rostowsky KA, Chowdhury NF, Hwang DH, Law EM. Brain segmentation from computed tomography of healthy aging and geriatric concussion at variable spatial resolutions. Front Neuroinform. 2019;13:9.CrossRef Irimia A, Maher AS, Rostowsky KA, Chowdhury NF, Hwang DH, Law EM. Brain segmentation from computed tomography of healthy aging and geriatric concussion at variable spatial resolutions. Front Neuroinform. 2019;13:9.CrossRef
15.
Zurück zum Zitat Rorden C, Bonilha L, Fridriksson J, Bender B, Karnath HO. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012;61:957–65.CrossRef Rorden C, Bonilha L, Fridriksson J, Bender B, Karnath HO. Age-specific CT and MRI templates for spatial normalization. Neuroimage. 2012;61:957–65.CrossRef
16.
Zurück zum Zitat Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839–51.CrossRef Ashburner J, Friston KJ. Unified segmentation. Neuroimage. 2005;26:839–51.CrossRef
17.
Zurück zum Zitat Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286:2703–10.CrossRef Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286:2703–10.CrossRef
18.
Zurück zum Zitat Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299-308.CrossRef Stevens RD, Marshall SA, Cornblath DR, Hoke A, Needham DM, de Jonghe B, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009;37:S299-308.CrossRef
19.
Zurück zum Zitat Oddo M, Taccone FS. How to monitor the brain in septic patients? Minerva Anestesiol. 2015;81:776–88.PubMed Oddo M, Taccone FS. How to monitor the brain in septic patients? Minerva Anestesiol. 2015;81:776–88.PubMed
20.
Zurück zum Zitat Polito A, Eischwald F, Maho AL, Polito A, Azabou E, Annane D, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17:R204.CrossRef Polito A, Eischwald F, Maho AL, Polito A, Azabou E, Annane D, et al. Pattern of brain injury in the acute setting of human septic shock. Crit Care. 2013;17:R204.CrossRef
21.
Zurück zum Zitat Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost. 2013;39:559–66.CrossRef Levi M, Schultz M, van der Poll T. Sepsis and thrombosis. Semin Thromb Hemost. 2013;39:559–66.CrossRef
22.
Zurück zum Zitat Chang JC. Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J. 2019;17:10.CrossRef Chang JC. Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J. 2019;17:10.CrossRef
23.
Zurück zum Zitat Sasannejad C, Ely EW, Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care. 2019;23:352.CrossRef Sasannejad C, Ely EW, Lahiri S. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care. 2019;23:352.CrossRef
24.
Zurück zum Zitat Chen H, Menon DK, Kavanagh BP. Impact of altered airway pressure on intracranial pressure, perfusion, and oxygenation: a narrative review. Crit Care Med. 2019;47:254–63.CrossRef Chen H, Menon DK, Kavanagh BP. Impact of altered airway pressure on intracranial pressure, perfusion, and oxygenation: a narrative review. Crit Care Med. 2019;47:254–63.CrossRef
25.
Zurück zum Zitat Nyquist P, Stevens RD, Mirski MA. Neurologic injury and mechanical ventilation. Neurocrit Care. 2008;9:400–8.CrossRef Nyquist P, Stevens RD, Mirski MA. Neurologic injury and mechanical ventilation. Neurocrit Care. 2008;9:400–8.CrossRef
26.
Zurück zum Zitat Muench E, Bauhuf C, Roth H, Horn P, Phillips M, Marquetant N, et al. Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med. 2005;33:2367–72.CrossRef Muench E, Bauhuf C, Roth H, Horn P, Phillips M, Marquetant N, et al. Effects of positive end-expiratory pressure on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation. Crit Care Med. 2005;33:2367–72.CrossRef
27.
Zurück zum Zitat Luce JM, Huseby JS, Kirk W, Butler J. A Starling resistor regulates cerebral venous outflow in dogs. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:1496–503.PubMed Luce JM, Huseby JS, Kirk W, Butler J. A Starling resistor regulates cerebral venous outflow in dogs. J Appl Physiol Respir Environ Exerc Physiol. 1982;53:1496–503.PubMed
28.
Zurück zum Zitat Lahiri S, Regis GC, Koronyo Y, Fuchs DT, Sheyn J, Kim EH, et al. Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer’s disease mice. Crit Care. 2019;23:63.CrossRef Lahiri S, Regis GC, Koronyo Y, Fuchs DT, Sheyn J, Kim EH, et al. Acute neuropathological consequences of short-term mechanical ventilation in wild-type and Alzheimer’s disease mice. Crit Care. 2019;23:63.CrossRef
29.
Zurück zum Zitat Gado M, Hughes CP, Danziger W, Chi D. Aging, dementia, and brain atrophy: a longitudinal computed tomographic study. AJNR Am J Neuroradiol. 1983;4:699–702.PubMedPubMedCentral Gado M, Hughes CP, Danziger W, Chi D. Aging, dementia, and brain atrophy: a longitudinal computed tomographic study. AJNR Am J Neuroradiol. 1983;4:699–702.PubMedPubMedCentral
30.
Zurück zum Zitat Kido T, Tabara Y, Igase M, Ochi N, Uetani E, Nagai T, et al. Postural instability is associated with brain atrophy and cognitive impairment in the elderly: the J-SHIPP study. Dement Geriatr Cogn Disord. 2010;29:379–87.CrossRef Kido T, Tabara Y, Igase M, Ochi N, Uetani E, Nagai T, et al. Postural instability is associated with brain atrophy and cognitive impairment in the elderly: the J-SHIPP study. Dement Geriatr Cogn Disord. 2010;29:379–87.CrossRef
31.
Zurück zum Zitat Luxenberg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology. 1987;37:1135–40.CrossRef Luxenberg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology. 1987;37:1135–40.CrossRef
32.
Zurück zum Zitat Rosano C, Aizenstein HJ, Studenski S, Newman AB. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2007;62:1048–55.CrossRef Rosano C, Aizenstein HJ, Studenski S, Newman AB. A regions-of-interest volumetric analysis of mobility limitations in community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2007;62:1048–55.CrossRef
33.
Zurück zum Zitat Tabatabaei-Jafari H, Shaw ME, Walsh E, Cherbuin N. Alzheimer’s disease neuroimaging initiative (ADNI). Regional brain atrophy predicts time to conversion to Alzheimer’s disease, dependent on baseline volume. Neurobiol Aging. 2019;83:86–94.CrossRef Tabatabaei-Jafari H, Shaw ME, Walsh E, Cherbuin N. Alzheimer’s disease neuroimaging initiative (ADNI). Regional brain atrophy predicts time to conversion to Alzheimer’s disease, dependent on baseline volume. Neurobiol Aging. 2019;83:86–94.CrossRef
34.
Zurück zum Zitat Comim CM, Barichello T, Grandgirard D, Dal-Pizzol F, Quevedo J, Leib SL. Caspase-3 mediates in part hippocampal apoptosis in sepsis. Mol Neurobiol. 2013;47:394–8.CrossRef Comim CM, Barichello T, Grandgirard D, Dal-Pizzol F, Quevedo J, Leib SL. Caspase-3 mediates in part hippocampal apoptosis in sepsis. Mol Neurobiol. 2013;47:394–8.CrossRef
35.
Zurück zum Zitat Schwalm MT, Pasquali M, Miguel SP, Dos Santos JP, Vuolo F, Comim CM, et al. Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats. Mol Neurobiol. 2014;49:380–5.CrossRef Schwalm MT, Pasquali M, Miguel SP, Dos Santos JP, Vuolo F, Comim CM, et al. Acute brain inflammation and oxidative damage are related to long-term cognitive deficits and markers of neurodegeneration in sepsis-survivor rats. Mol Neurobiol. 2014;49:380–5.CrossRef
36.
Zurück zum Zitat Rengel KF, Hayhurst CJ, Pandharipande PP, Hughes CG. Long-term cognitive and functional impairments after critical illness. Anesth Analg. 2019;128:772–80.CrossRef Rengel KF, Hayhurst CJ, Pandharipande PP, Hughes CG. Long-term cognitive and functional impairments after critical illness. Anesth Analg. 2019;128:772–80.CrossRef
37.
Zurück zum Zitat Fong TG, Bogardus ST Jr, Daftary A, Auerbach E, Blumenfeld H, Modur S, et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006;61:1294–9.CrossRef Fong TG, Bogardus ST Jr, Daftary A, Auerbach E, Blumenfeld H, Modur S, et al. Cerebral perfusion changes in older delirious patients using 99mTc HMPAO SPECT. J Gerontol A Biol Sci Med Sci. 2006;61:1294–9.CrossRef
38.
Zurück zum Zitat Yokota H, Ogawa S, Kurokawa A, Yamamoto Y. Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci. 2003;57:337–9.CrossRef Yokota H, Ogawa S, Kurokawa A, Yamamoto Y. Regional cerebral blood flow in delirium patients. Psychiatry Clin Neurosci. 2003;57:337–9.CrossRef
39.
Zurück zum Zitat Harvey MA, Davidson JE. Postintensive care syndrome: right care, right now… and later. Crit Care Med. 2016;44:381–5.CrossRef Harvey MA, Davidson JE. Postintensive care syndrome: right care, right now… and later. Crit Care Med. 2016;44:381–5.CrossRef
40.
Zurück zum Zitat Giorgio A, De Stefano N. Clinical use of brain volumetry. J Magn Reson Imaging. 2013;37:1–14.CrossRef Giorgio A, De Stefano N. Clinical use of brain volumetry. J Magn Reson Imaging. 2013;37:1–14.CrossRef
Metadaten
Titel
Rapidly progressive brain atrophy in septic ICU patients: a retrospective descriptive study using semiautomatic CT volumetry
verfasst von
Ryuta Nakae
Tetsuro Sekine
Takashi Tagami
Yasuo Murai
Eigo Kodani
Geoffrey Warnock
Hidetaka Sato
Akio Morita
Hiroyuki Yokota
Shoji Yokobori
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 1/2021
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-021-03828-7

Weitere Artikel der Ausgabe 1/2021

Critical Care 1/2021 Zur Ausgabe

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.